• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后营养指数(PNI):一种对接受腹膜后脂肪肉瘤手术患者更具前景的营养预测指标。

Prognostic Nutritional Index (PNI): A More Promising Nutritional Predictor for Patients Undergoing Surgery for Retroperitoneal Liposarcoma.

作者信息

Xue Guo-Qiang, Li Cheng-Peng, Lv Ang, Wu Jian-Hui, Tian Xiu-Yun, Qiu Hui, Hao Chunyi

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.

出版信息

Cancer Manag Res. 2024 Aug 13;16:1021-1030. doi: 10.2147/CMAR.S474801. eCollection 2024.

DOI:10.2147/CMAR.S474801
PMID:39157713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11330238/
Abstract

BACKGROUND

Extended surgery with multi-visceral resection is the standard treatment for retroperitoneal liposarcoma (RLPS). Malnutrition tends to result in increased surgical complications and reduced survival. The aim of this study was to identify the prognostic role of nutritional status in patients with RLPS.

PATIENTS AND METHODS

Data from 189 consecutive patients with RLPS who underwent surgical treatment at the Peking University Cancer Hospital Sarcoma Center between April 2011 and August 2022 were retrospectively reviewed. The following nutritional parameters were calculated: nutritional risk index, prognostic nutritional index (PNI) and Nutrition Risk Screening 2002. Time-dependent receiver operating characteristic (time-ROC) curve analysis was conducted to compare the prognostic utility of nutritional indicators. The associations between nutritional indicators and major complications, local recurrence-free survival (LRFS) and overall survival (OS) were investigated.

RESULTS

Based on the time-ROC curve analysis, the PNI was superior to other nutritional indices at predicting OS. The optimal cut-off value of PNI was 41.2. The PNI was significantly inversely associated with tumor size, tumor grade, and histological subtype. Patients in the low PNI group (< 41.2) had significantly shorter LRFS and OS than those in the high PNI (≥ 41.2) group, with higher major morbidity and mortality rates. The PNI was found to be a unique nutritional predictor that independently predicted LRFS and OS in the multivariate analysis.

CONCLUSION

The PNI is an effective tool for nutritional assessment in patients with RLPS. A low PNI value in patients with RLPS predicts worse survival outcomes.

摘要

背景

多脏器切除术的扩大手术是腹膜后脂肪肉瘤(RLPS)的标准治疗方法。营养不良往往会导致手术并发症增加和生存率降低。本研究的目的是确定营养状况在RLPS患者中的预后作用。

患者与方法

回顾性分析了2011年4月至2022年8月期间在北京大学肿瘤医院肉瘤中心接受手术治疗的189例连续性RLPS患者的数据。计算了以下营养参数:营养风险指数、预后营养指数(PNI)和营养风险筛查2002。进行了时间依赖性受试者操作特征(time-ROC)曲线分析,以比较营养指标的预后效用。研究了营养指标与主要并发症、无局部复发生存期(LRFS)和总生存期(OS)之间的关联。

结果

基于time-ROC曲线分析,PNI在预测OS方面优于其他营养指标。PNI的最佳截断值为41.2。PNI与肿瘤大小、肿瘤分级和组织学亚型显著负相关。低PNI组(<41.2)患者的LRFS和OS明显短于高PNI组(≥41.2),主要发病率和死亡率更高。在多变量分析中,PNI被发现是一个独立预测LRFS和OS的独特营养预测指标。

结论

PNI是RLPS患者营养评估的有效工具。RLPS患者PNI值低预示着生存结果较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/12305a401942/CMAR-16-1021-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/ba844b5f380a/CMAR-16-1021-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/e3c2080085ec/CMAR-16-1021-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/12305a401942/CMAR-16-1021-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/ba844b5f380a/CMAR-16-1021-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/e3c2080085ec/CMAR-16-1021-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd6/11330238/12305a401942/CMAR-16-1021-g0003.jpg

相似文献

1
Prognostic Nutritional Index (PNI): A More Promising Nutritional Predictor for Patients Undergoing Surgery for Retroperitoneal Liposarcoma.预后营养指数(PNI):一种对接受腹膜后脂肪肉瘤手术患者更具前景的营养预测指标。
Cancer Manag Res. 2024 Aug 13;16:1021-1030. doi: 10.2147/CMAR.S474801. eCollection 2024.
2
Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma.术前控制营养状况评分联合纤维蛋白原-白蛋白比值对腹膜后脂肪肉瘤患者术后无局部复发生存的预测价值
Cancer Manag Res. 2021 Aug 6;13:6157-6167. doi: 10.2147/CMAR.S307920. eCollection 2021.
3
[Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery].[术前预后营养指数作为手术治疗非转移性肾细胞癌预后的预测因素]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Feb 18;55(1):149-155. doi: 10.19723/j.issn.1671-167X.2023.01.023.
4
Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high‑volume sarcoma center: a propensity score matching analysis.高容量肉瘤中心腹膜后脂肪肉瘤的主要血管切除的手术结果:倾向评分匹配分析。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343. doi: 10.1007/s00432-024-05871-7.
5
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.术前预后营养指数在III期结肠癌患者中的预后价值及其与全身炎症反应标志物的相关性
Chin J Cancer. 2017 Dec 21;36(1):96. doi: 10.1186/s40880-017-0260-1.
6
Usefulness of the preoperative prognostic nutritional index score as a predictor of the outcomes of lung transplantation: A single-institution experience.术前预后营养指数评分作为肺移植结局预测指标的实用性:单中心经验。
Clin Nutr. 2019 Oct;38(5):2423-2429. doi: 10.1016/j.clnu.2018.10.027. Epub 2018 Nov 10.
7
Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis.来自高容量肉瘤中心的腹膜后脂肪肉瘤的肾切除术后短期和长期结果:倾向评分匹配分析。
Int J Clin Oncol. 2024 Jul;29(7):1035-1043. doi: 10.1007/s10147-024-02530-2. Epub 2024 Apr 23.
8
Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.控制营养状况(CONUT)评分是接受一线化疗的 III-IV 期 NSCLC 患者的预后标志物。
BMC Cancer. 2023 Mar 9;23(1):225. doi: 10.1186/s12885-023-10682-z.
9
The Value of Prognostic Nutritional Index (PNI) in Predicting Survival and Guiding Radiotherapy of Patients With T1-2N1 Breast Cancer.预后营养指数(PNI)在预测T1-2N1期乳腺癌患者生存率及指导放疗中的价值
Front Oncol. 2020 Jan 30;9:1562. doi: 10.3389/fonc.2019.01562. eCollection 2019.
10
Cholesterol-modified prognostic nutritional index (CPNI) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer.胆固醇修饰的预后营养指数(CPNI)作为一种有效的评估乳腺癌患者营养状况和预测生存的工具。
BMC Med. 2023 Dec 21;21(1):512. doi: 10.1186/s12916-023-03225-7.

引用本文的文献

1
Letter to the editor: Evaluation of sarcopenia's relationship with overall survival and treatment toxicity in soft tissue sarcomas.致编辑的信:评估肌肉减少症与软组织肉瘤总生存期及治疗毒性的关系
Support Care Cancer. 2025 Apr 8;33(5):363. doi: 10.1007/s00520-025-09416-7.
2
Prognostic value of prognostic nutritional index in patients with nasopharyngeal carcinoma treated with endostar and concurrent chemoradiotherapy.恩度联合同步放化疗治疗鼻咽癌患者中预后营养指数的预后价值
Support Care Cancer. 2025 Feb 26;33(3):226. doi: 10.1007/s00520-025-09280-5.

本文引用的文献

1
Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies.腹膜后软组织肉瘤:新兴治疗策略
Cancers (Basel). 2023 Nov 18;15(22):5469. doi: 10.3390/cancers15225469.
2
Six Surgical Stages in the Resection of Primary Right Retroperitoneal Liposarcoma: A Standardized Comprehensive Approach.原发性右腹膜后脂肪肉瘤切除术的六个手术阶段:一种标准化的综合方法。
Ann Surg Oncol. 2023 Oct;30(11):6896-6897. doi: 10.1245/s10434-023-13660-8. Epub 2023 Jun 10.
3
Primary retroperitoneal sarcoma: A comparison of survival outcomes in specialist and non-specialist sarcoma centres.
原发性腹膜后肉瘤:在专业肉瘤中心和非专业肉瘤中心的生存结果比较。
Eur J Cancer. 2023 Jul;188:20-28. doi: 10.1016/j.ejca.2023.04.004. Epub 2023 Apr 17.
4
Prognostic Utility of Nutritional Risk Index in Patients with Head and Neck Soft Tissue Sarcoma.营养风险指数对头颈部软组织肉瘤患者预后的预测价值。
Nutrients. 2023 Jan 26;15(3):641. doi: 10.3390/nu15030641.
5
Morbidity and Mortality after Surgery for Retroperitoneal Sarcoma.腹膜后肉瘤手术后的发病率和死亡率。
Curr Oncol. 2022 Dec 29;30(1):492-505. doi: 10.3390/curroncol30010039.
6
Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma.肌肉减少症和虚弱作为预测腹膜后肉瘤手术发病率和肿瘤学结果的指标。
J Surg Oncol. 2023 Apr;127(5):855-861. doi: 10.1002/jso.27199. Epub 2023 Jan 9.
7
Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma.在腹膜后脂肪肉瘤患者中,肌肉减少症与更严重的手术并发症相关,但与无复发生存和总生存无关。
World J Surg Oncol. 2022 Dec 20;20(1):404. doi: 10.1186/s12957-022-02846-1.
8
Short- and long-term surgical outcomes of pancreatic resection for retroperitoneal sarcoma: A long-term single-center experience of 90 cases.腹膜后肉瘤行胰腺切除术的短期和长期手术结果:90 例单中心长期经验。
J Surg Oncol. 2023 Mar;127(4):633-644. doi: 10.1002/jso.27160. Epub 2022 Nov 28.
9
Surgical Principles of Primary Retroperitoneal Sarcoma in the Era of Personalized Treatment: A Review of the Frontline Extended Surgery.个性化治疗时代原发性腹膜后肉瘤的外科原则:一线扩大手术综述
Cancers (Basel). 2022 Aug 24;14(17):4091. doi: 10.3390/cancers14174091.
10
How to treat liposarcomas located in retroperitoneum.如何治疗腹膜后部位的脂肪肉瘤。
Eur J Surg Oncol. 2023 Jun;49(6):1068-1080. doi: 10.1016/j.ejso.2022.04.020. Epub 2022 May 7.